Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry

NCT04150822 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04150822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04150822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2018
Completion date
June 30, 2028
Enrollment
296 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous malformation of brain, hereditary hemorrhagic telangiectasia, hht